The current CRISPR patent dispute, explained

Robert Merges quoted by California Magazine, April 27, 2017

“The good news is that Berkeley has pending CRISPR patents of its own, and these have been delayed due to the patent trial court case,” Merges said. “With that resolved, it’s anticipated the patent office will move ahead with Cal’s patent approval.”